Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins

被引:1056
作者
Karkkainen, MJ
Haiko, P
Sainio, K
Partanen, J
Taipale, J
Petrova, TV
Jeltsch, M
Jackson, DG
Talikka, M
Rauvala, H
Betsholtz, C
Alitalo, K
机构
[1] Univ Helsinki, Mol Canc Biol Lab, FIN-00014 Helsinki, Finland
[2] Univ Helsinki, Haartman Inst, Ludwig Inst Canc Res, FIN-00014 Helsinki, Finland
[3] Univ Helsinki, Univ Helsinki Hosp, Biomedicum Helsinki, FIN-00014 Helsinki, Finland
[4] Biomedicum Helsinki, Inst Biomed Dev Biol, Helsinki 00029, Finland
[5] HUCH Diagnost, Helsinki 00029, Finland
[6] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland
[7] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC, Human Immunol Unit, Oxford OX3 9DU, England
[8] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland
[9] Univ Gothenburg, Dept Biochem Med, S-40530 Gothenburg, Sweden
关键词
D O I
10.1038/ni1013
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Lymphatic vessels are essential for immune surveillance, tissue fluid homeostasis and fat absorption. Defects in lymphatic vessel formation or function cause lymphedema. Here we show that the vascular endothelial growth factor C (VEGF-C) is required for the initial steps in lymphatic development. In Vegfc(-/-) mice, endothelial cells commit to the lymphatic lineage but do not sprout to form lymph vessels. Sprouting was rescued by VEGF-C and VEGF-D but not by VEGF, indicating VEGF receptor 3 specificity. The lack of lymphatic vessels resulted in prenatal death due to fluid accumulation in tissues, and Vegfc(+/-) mice developed cutaneous lymphatic hypoplasia and lymphedema. Our results indicate that VEGF-C is the paracrine factor essential for lymphangiogenesis, and show that both Vegfc alleles are required for normal lymphatic development.
引用
收藏
页码:74 / 80
页数:7
相关论文
共 44 条
  • [1] Vascular endothelial growth factor-B-deficient mice display an atrial conduction defect
    Aase, K
    von Euler, G
    Li, X
    Pontén, A
    Thorén, P
    Cao, R
    Cao, Y
    Olofsson, B
    Gebre-Medhin, S
    Pekny, M
    Alitalo, K
    Betsholtz, C
    Eriksson, U
    [J]. CIRCULATION, 2001, 104 (03) : 358 - 364
  • [2] Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)
    Achen, MG
    Jeltsch, M
    Kukk, E
    Mäkinen, T
    Vitali, A
    Wilks, AF
    Alitalo, K
    Stacker, SA
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (02) : 548 - 553
  • [3] Embryonic expression pattern of the murine figf gene, a growth factor belonging to platelet-derived growth factor vascular endothelial growth factor family
    Avantaggiato, V
    Orlandini, M
    Acampora, D
    Oliviero, S
    Simeone, A
    [J]. MECHANISMS OF DEVELOPMENT, 1998, 73 (02) : 221 - 224
  • [4] The specificity of receptor binding by vascular endothelial growth factor-D is different in mouse and man
    Baldwin, ME
    Catimel, B
    Nice, EC
    Roufail, S
    Hall, NE
    Stenvers, KL
    Karkkainen, MJ
    Alitalo, K
    Stacker, SA
    Achen, MG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (22) : 19166 - 19171
  • [5] Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia
    Bellomo, D
    Headrick, JP
    Silins, GU
    Paterson, CA
    Thomas, PS
    Gartside, M
    Mould, A
    Cahill, MM
    Tonks, ID
    Grimmond, SM
    Townson, S
    Wells, C
    Little, M
    Cummings, MC
    Hayward, NK
    Kay, GF
    [J]. CIRCULATION RESEARCH, 2000, 86 (02) : E29 - E35
  • [6] Angiosarcomas express mixed endothelial phenotypes of blood and lymphatic capillaries -: Podoplanin as a specific marker for lymphatic endothelium
    Breiteneder-Geleff, S
    Soleiman, A
    Kowalski, H
    Horvat, R
    Amann, G
    Kriehuber, E
    Diem, K
    Weninger, W
    Tschachler, E
    Alitalo, K
    Kerjaschki, D
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 1999, 154 (02) : 385 - 394
  • [7] Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions
    Carmeliet, P
    Moons, L
    Luttun, A
    Vincenti, V
    Compernolle, V
    De Mol, M
    Wu, Y
    Bon, F
    Devy, L
    Beck, H
    Scholz, D
    Acker, T
    DiPalma, T
    Dewerchin, M
    Noel, A
    Stalmans, I
    Barra, A
    Blacher, S
    Vandendriessche, T
    Ponten, A
    Eriksson, U
    Plate, KH
    Foidart, JM
    Schaper, W
    Charnock-Jones, DS
    Hicklin, DJ
    Herbert, JM
    Collen, D
    Persico, MG
    [J]. NATURE MEDICINE, 2001, 7 (05) : 575 - 583
  • [8] Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
    Carmeliet, P
    Ferreira, V
    Breier, G
    Pollefeyt, S
    Kieckens, L
    Gertsenstein, M
    Fahrig, M
    Vandenhoeck, A
    Harpal, K
    Eberhardt, C
    Declercq, C
    Pawling, J
    Moons, L
    Collen, D
    Risau, W
    Nagy, A
    [J]. NATURE, 1996, 380 (6573) : 435 - 439
  • [9] Abnormal Development of Peripheral Lymphoid Organs in Mice Deficient in Lymphotoxin
    De Togni, Pietro
    Goellner, Josphe
    Ruddle, Nancy H.
    Streeter, Philip R.
    Fick, Andrea
    Mariathasan, Sanjeev
    Smith, Stacy C.
    Carison, Rebecca
    Shonnick, Laurie P.
    strauss-Schoenberger, Jena
    Russell, John H.
    Karr, Robert
    Chaplin, David D.
    [J]. JOURNAL OF IMMUNOLOGY, 2014, 192 (05) : 2010 - 2014
  • [10] Cardiovascular failure in mouse embryos deficient in VEGF receptor-3
    Dumont, DJ
    Jussila, L
    Taipale, J
    Lymboussaki, A
    Mustonen, T
    Pajusola, K
    Breitman, M
    Alitalo, K
    [J]. SCIENCE, 1998, 282 (5390) : 946 - 949